PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia
Brittany M. Curtiss, Jake VanCampen, Jommel Macaraeg, Garth Kong, Akram Taherinasab, Mitsuhiro Tsuchiya, William M. Yashar, Yiu Huen Tsang, Wesley Horton, Daniel J. Coleman, Joseph Estabrook, Theresa A. Lusardi, Gordon B. Mills, Brian Druker, Julia E. Maxson, Theodore P. Braun
Topics & Concepts
Myeloid leukemiaCancer researchDemethylaseBiologyProtein kinase BMyeloidLeukemiaPharmacologySignal transductionImmunologyCell biologyEpigeneticsGeneBiochemistryHistone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsAcute Myeloid Leukemia Research